Skip to main content
. 2016 Jul;4(14):272. doi: 10.21037/atm.2016.07.10

Table 2. Anti-PD-1: immune-related thyroiditis management guidance.

Thyroiditis Grade 1 Grade 2 Grade 3 Grade 4
Hypothyroidism Frequently monitor thyroid function and hormone levels Frequently monitor thyroid function and hormone levels
Consider consultation with endocrinologist
Continue anti-PD-1 therapy while treating thyroid disorder
Treat with thyroid hormone and/or steroid replacement therapy
Withhold anti-PD-1Treat with IV methylprednisolone followed by oral prednisone
Upon improvement to grade 1 or less, initiate corticosteroid taper and continue to taper over at least 1 month
Replacement of appropriate hormones may be required as the steroid dose is tapered
Discontinue anti-PD-1Consider endocrine consultation
Rule out infection and sepsis with culture assay and imaging
Treat with IV methylprednisolone followed by oral prednisone
Upon improvement to grade 1 or less, initiate corticosteroid taper and continue to taper over at least 1 month
Replacement of appropriate hormones may be required as the steroid dose is tapered
Hyperthyroidism For symptomatic hyperthyroidism, prescribe beta-blockers Administer corticosteroids
Upon improvement to grade 1 or less, initiate corticosteroid taper and continue to taper over at least 1 month
Withhold anti-PD-1Administer corticosteroids
Upon improvement to grade 1 or less, initiate corticosteroid taper and continue to taper over at least 1 month
Permanently discontinue anti-PD-1 for any adverse reaction that recurs
Discontinue anti-PD-1Administer corticosteroids
Upon improvement to grade 1 or less, initiate corticosteroid taper and continue to taper over at least 1 month

Over hypothyroidism: start levothyroxine replacement (I) if patient has both adrenal insufficiency and hypothyroidism, replace with hydrocortisone for 2–3 days before initiating levothyroxine (II) elderly patients or patients with heart diseases, start low and increase low.